Modernizing Drug Enforcement Act of 2019
- Last Action
- 5/31/2019
Actions
- 2019-05-31Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
- 2019-05-09Referred to the Subcommittee on Health.
- 2019-05-08Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-05-08Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-05-08Introduced in House
- 2019-05-08Introduced in House
CRS Summary
As of 2019-05-08 (00)
Modernizing Drug Enforcement Act of 2019
This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Cosponsors (1)
- Thomas Suozzi (D-NY)
Subjects
- Drug safety, medical device, and laboratory regulation
- Drug trafficking and controlled substances
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.